M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Brooklyn ImmunoTherapeutics, Inc. to acquire Novellus Therapeutics
Announced Jul 19, 2021 · Closed Jul 19, 2021 · Private target
Deal value$102M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationCash and stock
Transaction
- Acquirer
- Brooklyn ImmunoTherapeutics, Inc. (ERNA)
- Target
- Novellus Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jul 19, 2021
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations